Clomimed 50mg – Clomiphene Citrate – Deus Medical

$46.00

Availability: In Stock

Active Ingredient: Clomiphene Citrate (Clomid)

Teblets Count: 50 Tab

Molar Mass: 405.966 G/mol

Formula: C26h28clno

Trade Name: Clomidothers

Concentration: 50 mg/cap

Presentation: 50 Teblets (Total box 2500mg)

SKU: 101AAS-DM-0-119 Categories: , , ,

Reviews

There are no reviews yet.

Be the first to review “Clomimed 50mg – Clomiphene Citrate – Deus Medical”

Your email address will not be published. Required fields are marked *

Quick Comparison

SettingsClomimed 50mg – Clomiphene Citrate – Deus Medical removeClenzone - Clenbuterol 20mcg removeArimimed 1mg – Anastrozole – Deus Medical removeDianamed 10mg – Methandienone – Deus Medical removeLetrozole 2.5mg – Anti-estrogen, decreases fat build-up and decreases water retention removeAnadromed 50mg – Oxymetholone – Deus Medical remove
NameClomimed 50mg – Clomiphene Citrate – Deus Medical removeClenzone - Clenbuterol 20mcg removeArimimed 1mg – Anastrozole – Deus Medical removeDianamed 10mg – Methandienone – Deus Medical removeLetrozole 2.5mg – Anti-estrogen, decreases fat build-up and decreases water retention removeAnadromed 50mg – Oxymetholone – Deus Medical remove
Image
EU
EU
EU
EU
EU
EU
SKU101AAS-DM-0-119RF-AlphaZone-upline9986101AAS-DM-0-114101AAS-DM-0-117101AAS-HB-0-139101AAS-DM-0-112
Rating
Price $46.00$113.99 $60.00 $40.00 $75.00 $65.98
Stock

Out of stock

AvailabilityOut of stock
Add to cart

Add to cart

Read more

Add to cart

Add to cart

Add to cart

Add to cart

DescriptionActive Ingredient: Clomiphene Citrate (Clomid) Teblets Count: 50 Tab Molar Mass: 405.966 G/mol Formula: C26h28clno Trade Name: Clomidothers Concentration: 50 mg/cap Presentation: 50 Teblets (Total box 2500mg)Tablet Count: 100 tablets Dose: 20– 60mcg per day Cycle: 6-8 weeks. Bioavailability: 89–98% (orally) Molar mass: 277.19 Elimination half-life: 36–48 hours Metabolism: Hepatic (negligible) Acne: RARELY Water Retention: RARELY HBR: NO Hepatoxity: LOW Aromatization: YESActive: (anastrozole) Tabs Molar mass: 293.366 g/mol CAS ID: 120511-73-1 Formula: C17H19N5 Elimination half-life: 46.8 hours Trade name: Arimidex, others Metabolism: Liver (85%)
Active Ingredient: Methandienone 10mg Count: 100 Tabs Active Half-life: 5-6 Hours Classification: Anabolic Steroid Acne: Yes Concentration: 10 mg/cap Presentation: 100 Capsules (Total box 1000mg) Dosage: 20-80mg per day over the course of 6-8 weeks
CTIVE INGREDIENT: Letrozole 2.5mg TABLET COUNT: 30 COUNTS ACTIVE HALF-LIFE: 9 HOURS CLASSIFICATION: ANABOLIC STEROID DOSAGE: 2.5-5 MG/DAY ACNE: RARELY WATER RETENTION: NO HBR: NO HEPATOXITY: LOW AROMATIZATION: NO Ship From: EuropeWarehouse : EU 3(Dues Medical) Active Ingredient: Oxymetholone 50mg Tablet Count: 50 Tabs Concentration: 50 mg/Tab Presentation: 50 Tablet (Total box 2500mg) Dosage: 50-150mg per day over the course of 4-6 weeks Trade name: Anadrol, Anadromed, others Metabolism: Liver ATC code: A14AA05 (WHO)
ContentClenbuterol hydrochloride 0.02mg x 100 tablets Clenbuterol is a widely used bronchodilator in many parts of the world. The drug is most often prepared in 20mcg tablets, but it is also available in syrup and injectable form. Clenbuterol belongs to a broad group of drugs knows as sympathomimetics.Letrozole is a nonsteroidal inhibitor of estrogen synthesis with antineoplastic activity. As a third-generation aromatase inhibitor, Letrozole selectively and reversibly inhibits aromatase, which may result in growth inhibition of estrogen-dependent breast cancer cells. Aromatase, a cytochrome P-450 enzyme localized to the endoplasmic reticulum of the cell and found in many tissues including those of the premenopausal ovary, liver, and breast, catalyzes the aromatization of androstenedione and testosterone into estrone and estradiol, the final step in estrogen biosynthesis. Estrogens are produced by the conversion of androgens through the activity of the aromatase enzyme. Letrozole blocks production of estrogens in this way by competitive, reversible binding to the heme of its cytochrome P450 unit. The action is specific, and letrozole does not reduce production of mineralo- or corticosteroids. In contrast, the antiestrogenic action of tamoxifen, the major medical therapy prior to the arrival of aromatase inhibitors, is due to its interfering with the estrogen receptor, rather than inhibiting estrogen production. Letrozole is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women. Side effects include signs and symptoms of hypoestrogenism. There is concern that long term use may lead to osteoporosis, which is why prescriptions of Letrozole are often accompanied by prescriptions of osteoporosis-fighting medication such as Fosamax. Letrozole has shown to reduce estrogen levels by 98 percent while raising testosterone levels. The anti-estrogen action of letrozole is preferred by athletes and bodybuilders for use during a steroid cycle to reduce bloating due to excess water retention and prevent the formation of gynecomastia related breast tissue that is a side effect of some anabolic steroids. Usage above 2.5 mg/day is known to potentially temporarily kill sex drive. Above 5mg/day for extended periods may cause kidney problems. Letrozole has also been shown to delay the fusing of the growth plates in adolescents. This may boost the effectiveness of growth hormone, and thus Letrozole is used to treat adolescents and children with short stature.
Weight
DimensionsN/AN/AN/AN/AN/AN/A
Additional information